Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04380454 · ClinicalTrials.gov registry record · NA
Biomechanical and Neural Mechanisms of Post-stroke Gait Training
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
NCT04380454: Completed NA study, sponsored by Emory University.
NCT04380454 is a NA study that has completed, run by Emory University. The registered enrollment target is 55 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04380454, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
Study Summary
The study seeks to develop an understanding of how, why, and for whom fast treadmill walking (Fast) and Fast with functional electrical stimulation (FastFES) induce clinical benefits, allowing future development of cutting-edge, individually-tailored gait treatments that enhance both gait quality and gait function.
Primary Outcome
Propulsive asymmetry between the non-paretic and paretic peak anterior ground reaction forces (AGRF) has been shown to correlate with walking function. Propulsion, evaluated through AGRF, is crucial for propelling the body forward. Gait biomechanics testing is conducted in the motion analysis assessing gait asymmetry. A 7-camera system is used to collect motion analysis data. Ground reaction forces during treadmill walking will be collected using force platforms.
Interventions
- DEVICE Functional electrical stimulation (FES)
- OTHER Fast treadmill walking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2021-03-16 |
| Est. Completion | 2025-10-01 |
| Phase | NA |
What the finished NCT04380454 record still lists
NCT04380454 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 55 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which Functional electrical stimulation (FES) is the first listed.
NCT04380454 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04380454 about?
NCT04380454 is a clinical study titled "Biomechanical and Neural Mechanisms of Post-stroke Gait Training". The study seeks to develop an understanding of how, why, and for whom fast treadmill walking (Fast) and Fast with functional electrical stimulation (FastFES) induce clinical benefits, allowing future development of cutting-edge, individually-tailored gait treatments that enhance both gait quality an...
What is the current status of trial NCT04380454?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2021-03-16. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT04380454?
The interventions under investigation include: Functional electrical stimulation (FES) (DEVICE), Fast treadmill walking (OTHER).
Who is sponsoring clinical trial NCT04380454?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04380454's enrollment target sits among peer trials
55 1264th of 2000 higher than 733 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI